» Articles » PMID: 27681877

Community Acquired Respiratory Virus Infections in Cancer Patients-Guideline on Diagnosis and Management by the Infectious Diseases Working Party of the German Society for Haematology and Medical Oncology

Abstract

Background: Community acquired viruses (CRVs) may cause severe disease in cancer patients. Thus, efforts should be made to diagnose CRV rapidly and manage CRV infections accordingly.

Methods: A panel of 18 clinicians from the Infectious Diseases Working Party of the German Society for Haematology and Medical Oncology have convened to assess the available literature and provide recommendations on the management of CRV infections including influenza, respiratory syncytial virus, parainfluenza virus, human metapneumovirus and adenovirus.

Results: CRV infections in cancer patients may lead to pneumonia in approximately 30% of the cases, with an associated mortality of around 25%. For diagnosis of a CRV infection, combined nasal/throat swabs or washes/aspirates give the best results and nucleic acid amplification based-techniques (NAT) should be used to detect the pathogen. Hand hygiene, contact isolation and face masks have been shown to be of benefit as general infection management. Causal treatment can be given for influenza, using a neuraminidase inhibitor, and respiratory syncytial virus, using ribavirin in addition to intravenous immunoglobulins. Ribavirin has also been used to treat parainfluenza virus and human metapneumovirus, but data are inconclusive in this setting. Cidofovir is used to treat adenovirus pneumonitis.

Conclusions: CRV infections may pose a vital threat to patients with underlying malignancy. This guideline provides information on diagnosis and treatment to improve the outcome.

Citing Articles

Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report.

Salmanton-Garcia J, Marchesi F, Navratil M, Piukovics K, Del Principe M, Criscuolo M Am J Hematol. 2024; 100(3):358-374.

PMID: 39715069 PMC: 11803548. DOI: 10.1002/ajh.27565.


Microbiological risk factors, ICU survival, and 1-year survival in hematological patients with pneumonia requiring invasive mechanical ventilation.

Seybold B, Funk T, Dreger P, Egerer G, Brandt J, Mueller-Tidow C Eur J Clin Microbiol Infect Dis. 2024; 43(9):1679-1688.

PMID: 38922376 PMC: 11349809. DOI: 10.1007/s10096-024-04883-y.


Improving Influenza Vaccination Coverage in Patients with Cancer: A Position Paper from a Multidisciplinary Expert Group.

Bonanni P, Maio M, Beretta G, Icardi G, Rossi A, Cinieri S Vaccines (Basel). 2024; 12(4).

PMID: 38675802 PMC: 11053698. DOI: 10.3390/vaccines12040420.


Approach to fever in patients with neutropenia: a review of diagnosis and management.

Keck J, Wingler M, Cretella D, Vijayvargiya P, Wagner J, Barber K Ther Adv Infect Dis. 2022; 9:20499361221138346.

PMID: 36451936 PMC: 9703488. DOI: 10.1177/20499361221138346.


SARS-CoV-2 in immunocompromised individuals.

DeWolf S, Laracy J, Perales M, Kamboj M, van den Brink M, Vardhana S Immunity. 2022; 55(10):1779-1798.

PMID: 36182669 PMC: 9468314. DOI: 10.1016/j.immuni.2022.09.006.


References
1.
Chu H, Englund J, Podczervinski S, Kuypers J, Campbell A, Boeckh M . Nosocomial transmission of respiratory syncytial virus in an outpatient cancer center. Biol Blood Marrow Transplant. 2014; 20(6):844-51. PMC: 4036533. DOI: 10.1016/j.bbmt.2014.02.024. View

2.
Singh M, Singh M . Heated, humidified air for the common cold. Cochrane Database Syst Rev. 2013; (6):CD001728. DOI: 10.1002/14651858.CD001728.pub5. View

3.
Hayden F, Diamond L, Wood P, Korts D, Wecker M . Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1996; 125(2):89-97. DOI: 10.7326/0003-4819-125-2-199607150-00002. View

4.
MacFarlane P, Denham J, Assous J, Hughes C . RSV testing in bronchiolitis: which nasal sampling method is best?. Arch Dis Child. 2005; 90(6):634-5. PMC: 1720448. DOI: 10.1136/adc.2004.065144. View

5.
Hayden F, Sperber S, Belshe R, Clover R, Hay A, Pyke S . Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine. Antimicrob Agents Chemother. 1991; 35(9):1741-7. PMC: 245261. DOI: 10.1128/AAC.35.9.1741. View